Clinical Trial Update: Study to Assess Efficacy,Safety and Tolerability of Idebenone in the Treatment of Leber's Hereditary Optic Neuropathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating idebenone for efficacy, safety, and tolerability in Leber's Hereditary Optic Neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leber Hereditary Optic Neuropathy

Drugs mentioned

• Idebenone (idebenone)

Snippet

Sponsor: Santhera Pharmaceuticals | Conditions: Leber's Hereditary Optic Neuropathy | Phase 2 | Status: COMPLETED